BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36154569)

  • 1. Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications.
    Plowman TJ; Shah MH; Fernandez E; Christensen H; Aiges M; Ramana KV
    Curr Mol Med; 2023; 23(9):901-920. PubMed ID: 36154569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic complications and dysregulated innate immunity.
    Graves DT; Kayal RA
    Front Biosci; 2008 Jan; 13():1227-39. PubMed ID: 17981625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose Reductase Mediates NLRP3 Inflammasome-Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice.
    Pal PB; Sonowal H; Shukla K; Srivastava SK; Ramana KV
    Endocrinology; 2017 Oct; 158(10):3661-3675. PubMed ID: 28938395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on Cellular and Molecular Mechanisms Linked to the Development of Diabetes Complications.
    Babel RA; Dandekar MP
    Curr Diabetes Rev; 2021; 17(4):457-473. PubMed ID: 33143626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications.
    Papachristoforou E; Lambadiari V; Maratou E; Makrilakis K
    J Diabetes Res; 2020; 2020():7489795. PubMed ID: 33123598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.
    Fiorentino TV; Prioletta A; Zuo P; Folli F
    Curr Pharm Des; 2013; 19(32):5695-703. PubMed ID: 23448484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
    Wan TT; Li XF; Sun YM; Li YB; Su Y
    Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia and the pathobiology of diabetic complications.
    Aronson D
    Adv Cardiol; 2008; 45():1-16. PubMed ID: 18230953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
    Kang Q; Yang C
    Redox Biol; 2020 Oct; 37():101799. PubMed ID: 33248932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia.
    Osawa T; Kato Y
    Ann N Y Acad Sci; 2005 Jun; 1043():440-51. PubMed ID: 16037265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of NLRP3 inflammasome in diabetic neuropathy and prevention and treatment with traditional Chinese medicine].
    Feng HY; Ding R; Zhou Q; Wu TC; Li H; Ma XT; Yue RS
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):300-310. PubMed ID: 36725219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Short-Term Hyperglycemia on the Innate Immune System.
    Jafar N; Edriss H; Nugent K
    Am J Med Sci; 2016 Feb; 351(2):201-11. PubMed ID: 26897277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
    Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
    Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards newer molecular targets for chronic diabetic complications.
    Khan ZA; Farhangkhoee H; Chakrabarti S
    Curr Vasc Pharmacol; 2006 Jan; 4(1):45-57. PubMed ID: 16472176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Detailed Review of Molecular Pathways and Mechanisms Responsible for the Development and Aggravation of Neuropathy and Nephropathy in Diabetes.
    Chandra P; Sachan N; Saraswat N; Vyawahare N
    Curr Mol Pharmacol; 2024; 17(1):e280323215026. PubMed ID: 37018534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxidative stress and NF-kappaB activation in late diabetic complications.
    Mohamed AK; Bierhaus A; Schiekofer S; Tritschler H; Ziegler R; Nawroth PP
    Biofactors; 1999; 10(2-3):157-67. PubMed ID: 10609877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular death, reactive oxygen species (ROS) and diabetic complications.
    Volpe CMO; Villar-Delfino PH; Dos Anjos PMF; Nogueira-Machado JA
    Cell Death Dis; 2018 Jan; 9(2):119. PubMed ID: 29371661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.